We understand that businesses within life science face a rapidly evolving landscape with frequently changing regulatory requirements and a range of emerging risks.

— INDUSTRY

Life Sciences

Managing risk to protect your innovations

Contact us

Flexible approach, local knowledge, and a global reach

We understand that businesses within life science face a rapidly evolving landscape with frequently changing regulatory requirements and a range of emerging risks.

We have an intense focus on client service and a real passion to challenge and explore every aspect of risk associated with your business. This gives you the assurance of having a program that is tailored to your unique requirements.

In a changing insurance market, as specialists, we challenge our clients with fresh thinking and work with them to develop quality risk profiles to present to underwriters for optimum outcomes.

Being the world’s largest privately-owned insurance broker, our clients benefit from the strong relationships Lockton has built with domestic and international providers.

Our own Global Healthcare Network, gives us powerful leverage within the marketplace to successfully deliver cost-effective, bespoke insurance programs for each client’s individual requirements; without jeopardising coverage.

A creative and expanding range of solutions

We understand that the life sciences industry is different and a customised program is crucial in protecting businesses involved in pharmaceutical, research and development, medical device manufacturing, and human clinical trials. When it comes to managing risk it’s the quality of our thinking and our proactive approach that makes us different.

We also recognise the executive risk challenges faced by boards across the spectrum of life sciences and pharmaceutical companies, particularly those listed on the ASX. Whether it be renewal of your D&O liability insurance, coverage for a forthcoming initial public offering or new capital raising, we will work closely with you to ensure your program reflects your own risk appetite at a competitive premium.

Lockton is a member of AusBiotech, the leading Australian industry body representing and advocating for organisations doing business in and with the global life sciences economy.

Products and Services

By understanding what you do and what your individual needs are, we ensure there are no coverage gaps or overlaps within your insurance program including:

  • Life Science Insurance 

  • Clinical Trials Insurance, along with the ability to deliver quick issuance of certification

  • Product Liability

  • Property and Business Interruption, including supply chain risk

  • Professional Indemnity 

  • Directors & Officers

  • Cyber

  • Other specialised life sciences services, such as:

    • product recall;

    • medical malpractice;

    • supply chain risk review;

    • marine cargo;

    • employee benefits; and

    • additional industry solutions.

An industry-leading team of experts focused on the unique risks facing the life sciences industry.

Key Contacts

Placeholder image

Robert Giardina

Manager - Global Professional & Financial Risks
robert.giardina@lockton.com
+61 455 129 332

Questions? We'll guide you in the right direction.

Ask us about our products, services or anything else on your mind. Our insurance and risk specialists are here to help.

Contact us

Latest from Lockton

What does ASD Essentials mean for Australian organisations? Explore the shift beyond the Essential Eight and the implications for cyber risk and insurance.Beyond the Essential Eight

2027 Global Healthcare Cost Trends

Get the latest global healthcare cost projections, regional trends, emerging risks, and practical actions.Get the latest global healthcare cost projections, regional trends, emerging risks, and practical actions.

Healthcare Professional Liability Insurance Market Update 2026

Q4 2026 update on Australia’s HPL insurance market, covering capacity, claims costs and underwriting trends.Q4 2026 update on Australia’s HPL insurance market, covering capacity, claims costs and underwriting trends.

Lockton celebrates record-breaking year at the MACA Cancer 200

Lockton has celebrated a record-breaking year at the 2026 MACA Cancer 200 raising an incredible $95,655.46 for cancer research, our highest fundraising total in a single year.Lockton has celebrated a record-breaking year at the 2026 MACA Cancer 200 raising an incredible $95,655.46 for cancer research, our highest fundraising total in a single year.
See all news and insights

With a global footprint of 150+ offices and partner offices, find one near you.

Find an office
global communication network concept